Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge
about
Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion proteinNewcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategiesPriming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challengeReplication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.Vaccinia virus vectors: new strategies for producing recombinant vaccines.The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.Structure and function of respiratory syncytial virus surface glycoproteins.Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.Virally delivered cytokines alter the immune response to future lung infectionsDistinct types of lung disease caused by functional subsets of antiviral T cells.Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived.Measles virus nucleocapsid protein protects rats from encephalitis.Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antA subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop.Nucleotide sequence analysis and expression from recombinant vectors demonstrate that the attachment protein G of bovine respiratory syncytial virus is distinct from that of human respiratory syncytial virus.Increased expression in vivo and in vitro of foreign genes directed by A-type inclusion body hybrid promoters in recombinant vaccinia viruses.The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.Synthesis, cellular location, and immunogenicity of bovine herpesvirus 1 glycoproteins gI and gIII expressed by recombinant vaccinia virusStructure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation.Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated miceHigh-frequency homologous recombination in vaccinia virus DNA.Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice.Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.Differentiation of respiratory syncytial virus subgroups with cDNA probes in a nucleic acid hybridization assay.Influence of respiratory syncytial virus strain differences on pathogenesis and immunity.Detection of antibodies to respiratory syncytial virus attachment and nucleocapsid proteins with recombinant baculovirus-expressed antigensThe membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons.Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies.Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.
P2860
Q33554501-47A8FFA3-4E2D-4A69-A1FF-FAAF0F3C01CCQ33558475-2A325537-9B1A-47FF-99CE-9E05B344A69DQ33613442-BEE9A265-33EF-44DE-88EF-B1D16AB7F28FQ33783066-4D25CFCF-D1F4-4728-9C4A-26400BBF1D33Q33849224-38AEC759-6476-4718-B0CB-60164829F92DQ34211635-7A5A363C-7CBF-40B8-A588-7E51CB9C9C4CQ34337480-FD2E32E6-A726-4178-9B13-A0934C8C08EAQ34414405-801BBBE0-D616-4581-81D9-891592126434Q35488618-6DBD3821-8E73-4678-9235-179A719BE88AQ36315800-E8AC4C6D-125F-45FC-B5E1-B64E9D85DB7EQ36362647-EB033F73-4DA7-4D2B-8008-C07EA542782FQ36400958-E3337AF7-4F7B-4531-BB32-ED84DA1C35EEQ36683018-FF2424B1-B70A-42FF-B0FE-9AD2C274EAEFQ36683453-AFD62FA2-06BB-4422-8166-102C53FD44D8Q36691093-DFB757C5-500D-4264-8068-B71BDB07B1F4Q36784330-FD77257F-6516-4551-8719-0FDB6420E19FQ36793445-EC0561D3-9D65-4E07-A275-B72F2D93D474Q36798603-05307D01-8121-40BB-8767-05AC42067064Q36803727-E65E0182-BA26-494B-BC22-D1F519C0B8B1Q36827447-20184451-D735-48F9-9480-A820DD576FCEQ36831654-C42A0387-3E30-4C8E-BB6D-82AE57D985EAQ36875715-BE1B7130-FDE7-4B51-8533-1B8CB7B9D820Q36884312-B94B5347-195C-421F-B18C-AB71E9FAE8A9Q36888529-FE248186-4188-41CF-82BD-F4ECB4C9A264Q36918751-820227D8-F5ED-4A14-93A7-311FE3ED99C2Q36919232-C359BFB0-5ECC-4D4E-801D-80D1EEB54DFFQ36920250-3D2864A5-9E9D-4367-B8E7-3CE07BD5898DQ37153108-93E784BB-0370-40AF-AD37-D2EE4C1D58CCQ37187290-42E93F50-A819-43FB-94ED-8062BEF672A8Q39289416-82A45939-4625-4521-8B04-92671A055131Q40012955-6CBD7BD0-A49E-479E-954F-C6ADC1EE2F94Q40038247-1F8025A5-DEE7-445E-9E04-B61BFC2C61F8Q40130924-55EF87AC-B768-405B-945F-31B3F418BC17Q40308643-62F91A2B-8AF1-4410-BC37-DDE8EC58BAFE
P2860
Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge
description
1986 nî lūn-bûn
@nan
1986 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Human respiratory syncytial vi ...... e against live-virus challenge
@ast
Human respiratory syncytial vi ...... e against live-virus challenge
@en
type
label
Human respiratory syncytial vi ...... e against live-virus challenge
@ast
Human respiratory syncytial vi ...... e against live-virus challenge
@en
prefLabel
Human respiratory syncytial vi ...... e against live-virus challenge
@ast
Human respiratory syncytial vi ...... e against live-virus challenge
@en
P2093
P2860
P1433
P1476
Human respiratory syncytial vi ...... e against live-virus challenge
@en
P2093
P2860
P304
P407
P577
1986-11-01T00:00:00Z